PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: yaelpotash@gmail.com.\', \'Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel.\', \'Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Ministry of Health, Tel-Hashomer, Israel.\', \'Central Virology Laboratory, Ministry of Health, Tel-Hashomer, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1053-2498(21)02481-510.1016/j.healun.2021.08.010
?:hasPublicationType
?:journal
  • The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
is ?:pmid of
?:pmid
?:pmid
  • 34565682
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all